cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1998; 32:305-310
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sirnes, P. A.
Right arrow Articles by Kjekshus, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sirnes, P. A.
Right arrow Articles by Kjekshus, J.

Sustained benefit of stenting chronic coronary occlusion: long-term clinical follow-up of the Stenting in Chronic Coronary Occlusion (SICCO) study

Per Anton Sirnes, MD, Svein Golf, MD, PhDa, Yngvar Myreng, MD, PhDa, Per Mølstad, MD, PhDa, Per Albertsson, MD, PhD*, Arild Mangschau, MD, PhD{dagger}, Knut Endresen, MD, PhD{ddagger} and John Kjekshus, MD, PhD{ddagger}

a The Feiring Heart Clinic, Feiring, Norway
* Sahlgrenska University Hospital, Göteborg, Sweden
{dagger} Ullevål Hospital, Oslo, Norway
{ddagger} National Hospital, Oslo, Norway



View larger version (12K):

[in a new window]
 
Figure 1 Survival without major adverse clinical events (death, AMI, TVR, reocclusion). Solid line = stent group; dashed line = PTCA group.

 


View larger version (11K):

[in a new window]
 
Figure 2 Target vessel revascularization. Solid line= stent group; dashed line = PTCA group.

 




 
  cardiology careers collections past issues search home